Loading…
Non-specific in vivo inhibition of CK1 by the pyridinyl imidazole p38 inhibitors SB 203580 and SB 202190
Small-molecule inhibitors of protein kinases have contributed immensely to our understanding of biological signaling pathways and have been exploited therapeutically for the treatment of cancers and other disease states. The pyridinyl imidazole compounds SB 203580 and SB 202190 were identified as AT...
Saved in:
Published in: | BMB reports 2009-03, Vol.42 (3), p.142-147 |
---|---|
Main Authors: | , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c545t-662e1cf0abe5aceeee60e1c5800a8d47d83828cf8342cb6a058d678dc70e7a883 |
---|---|
cites | cdi_FETCH-LOGICAL-c545t-662e1cf0abe5aceeee60e1c5800a8d47d83828cf8342cb6a058d678dc70e7a883 |
container_end_page | 147 |
container_issue | 3 |
container_start_page | 142 |
container_title | BMB reports |
container_volume | 42 |
creator | Shanware, Naval P. (The University of Wisconsin-Madison Medical School, WI, Madison, USA) Williams, Leah M. (The University of Wisconsin-Madison Medical School, WI, Madison, USA) Bowler, Michael J. (The University of Wisconsin-Madison Medical School, WI, Madison, USA) Tibbetts, Randal S. (The University of Wisconsin-Madison Medical School, WI, Madison, USA), E-mail: rstibbetts@wisc.edu |
description | Small-molecule inhibitors of protein kinases have contributed immensely to our understanding of biological signaling pathways and have been exploited therapeutically for the treatment of cancers and other disease states. The pyridinyl imidazole compounds SB 203580 and SB 202190 were identified as ATP competitive antagonists of the p38 stress-activated protein kinases and have been widely used to elucidate p38-dependent cellular processes. Here, we identify S8 203580 and SB 202190 as potent inhibitors of stress-induced CREB phosphorylation on Serine 111 (Ser-111) in intact cells. Unexpectedly, we found that the inhibitory activity of SB 203580 and SB 202190 on CREB phosphorylation was independent of p38, but instead correlated with inhibition of casein kinase 1 (CK1) in vitro. The inhibition of CK1-mediated CREB phosphorylation by concentrations of pyridinyl imidazoles commonly employed to suppress p38, suggests that in some cases conclusions of p38-dependence derived solely from the use of these inhibitors may be invalid. |
doi_str_mv | 10.5483/bmbrep.2009.42.3.142 |
format | article |
fullrecord | <record><control><sourceid>pubmed_cross</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4412876</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>19336000</sourcerecordid><originalsourceid>FETCH-LOGICAL-c545t-662e1cf0abe5aceeee60e1c5800a8d47d83828cf8342cb6a058d678dc70e7a883</originalsourceid><addsrcrecordid>eNpVkNtKAzEQhoMoWqtvoJIX6Do5bJK9EWzxhFWhKngXstmsjbSbJVsL9elNqcfcTObP_N-EH6EjAlnOFTst52V0bUYBiozTjGWE0y3UI4UUAyHhZfv7Lgqxh_a77g1AECrpLtojBWMCAHpoeh-aQdc662tvsW_w0i9DqlNf-oUPDQ41Ht0SXK7wYupwu4q-8s1qhv3cV-YjzJLG1LchxA4_DjEFlivApqk2HSUFHKCd2sw6d_hV--j58uJpdD0YP1zdjM7HA5vzfJF-Sx2xNZjS5ca6dAQkIeHAqIrLSjFFla0V49SWwkCuKiFVZSU4aZRifXS24bbv5dxV1jWLaGa6jX5u4koH4_X_l8ZP9WtYas4JVVIkAN8AbAxdF1394yWg18nr4d1w4lq9Tl5zqplOySfbyd-9v6avqNPA8WagNkGb1-g7fTtZMwA4kzn7BNYUiL4</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Non-specific in vivo inhibition of CK1 by the pyridinyl imidazole p38 inhibitors SB 203580 and SB 202190</title><source>Free Full-Text Journals in Chemistry</source><creator>Shanware, Naval P. (The University of Wisconsin-Madison Medical School, WI, Madison, USA) ; Williams, Leah M. (The University of Wisconsin-Madison Medical School, WI, Madison, USA) ; Bowler, Michael J. (The University of Wisconsin-Madison Medical School, WI, Madison, USA) ; Tibbetts, Randal S. (The University of Wisconsin-Madison Medical School, WI, Madison, USA), E-mail: rstibbetts@wisc.edu</creator><creatorcontrib>Shanware, Naval P. (The University of Wisconsin-Madison Medical School, WI, Madison, USA) ; Williams, Leah M. (The University of Wisconsin-Madison Medical School, WI, Madison, USA) ; Bowler, Michael J. (The University of Wisconsin-Madison Medical School, WI, Madison, USA) ; Tibbetts, Randal S. (The University of Wisconsin-Madison Medical School, WI, Madison, USA), E-mail: rstibbetts@wisc.edu</creatorcontrib><description>Small-molecule inhibitors of protein kinases have contributed immensely to our understanding of biological signaling pathways and have been exploited therapeutically for the treatment of cancers and other disease states. The pyridinyl imidazole compounds SB 203580 and SB 202190 were identified as ATP competitive antagonists of the p38 stress-activated protein kinases and have been widely used to elucidate p38-dependent cellular processes. Here, we identify S8 203580 and SB 202190 as potent inhibitors of stress-induced CREB phosphorylation on Serine 111 (Ser-111) in intact cells. Unexpectedly, we found that the inhibitory activity of SB 203580 and SB 202190 on CREB phosphorylation was independent of p38, but instead correlated with inhibition of casein kinase 1 (CK1) in vitro. The inhibition of CK1-mediated CREB phosphorylation by concentrations of pyridinyl imidazoles commonly employed to suppress p38, suggests that in some cases conclusions of p38-dependence derived solely from the use of these inhibitors may be invalid.</description><identifier>ISSN: 1976-6696</identifier><identifier>EISSN: 1976-670X</identifier><identifier>DOI: 10.5483/bmbrep.2009.42.3.142</identifier><identifier>PMID: 19336000</identifier><language>eng</language><publisher>Korea (South)</publisher><subject>Casein kinase ; Casein Kinase I - antagonists & inhibitors ; Cell Line ; CICLOHEXIMIDA ; CK1 ; CK2 ; CREB ; Cyclic AMP Response Element-Binding Protein - metabolism ; CYCLOHEXIMIDE ; Humans ; Imidazoles - pharmacology ; Non-specific ; p38 ; p38 Mitogen-Activated Protein Kinases - antagonists & inhibitors ; Phosphorylation - drug effects ; Phosphoserine - metabolism ; Protein Biosynthesis - drug effects ; Protein Kinase Inhibitors - pharmacology ; Pyridines - pharmacology ; SB202190 ; SB203580 ; Stress, Physiological - drug effects ; Stress-activated protein kinase ; Substrate Specificity - drug effects ; Suppression, Genetic - drug effects</subject><ispartof>BMB reports, 2009-03, Vol.42 (3), p.142-147</ispartof><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c545t-662e1cf0abe5aceeee60e1c5800a8d47d83828cf8342cb6a058d678dc70e7a883</citedby><cites>FETCH-LOGICAL-c545t-662e1cf0abe5aceeee60e1c5800a8d47d83828cf8342cb6a058d678dc70e7a883</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,776,780,881,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/19336000$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Shanware, Naval P. (The University of Wisconsin-Madison Medical School, WI, Madison, USA)</creatorcontrib><creatorcontrib>Williams, Leah M. (The University of Wisconsin-Madison Medical School, WI, Madison, USA)</creatorcontrib><creatorcontrib>Bowler, Michael J. (The University of Wisconsin-Madison Medical School, WI, Madison, USA)</creatorcontrib><creatorcontrib>Tibbetts, Randal S. (The University of Wisconsin-Madison Medical School, WI, Madison, USA), E-mail: rstibbetts@wisc.edu</creatorcontrib><title>Non-specific in vivo inhibition of CK1 by the pyridinyl imidazole p38 inhibitors SB 203580 and SB 202190</title><title>BMB reports</title><addtitle>BMB Rep</addtitle><description>Small-molecule inhibitors of protein kinases have contributed immensely to our understanding of biological signaling pathways and have been exploited therapeutically for the treatment of cancers and other disease states. The pyridinyl imidazole compounds SB 203580 and SB 202190 were identified as ATP competitive antagonists of the p38 stress-activated protein kinases and have been widely used to elucidate p38-dependent cellular processes. Here, we identify S8 203580 and SB 202190 as potent inhibitors of stress-induced CREB phosphorylation on Serine 111 (Ser-111) in intact cells. Unexpectedly, we found that the inhibitory activity of SB 203580 and SB 202190 on CREB phosphorylation was independent of p38, but instead correlated with inhibition of casein kinase 1 (CK1) in vitro. The inhibition of CK1-mediated CREB phosphorylation by concentrations of pyridinyl imidazoles commonly employed to suppress p38, suggests that in some cases conclusions of p38-dependence derived solely from the use of these inhibitors may be invalid.</description><subject>Casein kinase</subject><subject>Casein Kinase I - antagonists & inhibitors</subject><subject>Cell Line</subject><subject>CICLOHEXIMIDA</subject><subject>CK1</subject><subject>CK2</subject><subject>CREB</subject><subject>Cyclic AMP Response Element-Binding Protein - metabolism</subject><subject>CYCLOHEXIMIDE</subject><subject>Humans</subject><subject>Imidazoles - pharmacology</subject><subject>Non-specific</subject><subject>p38</subject><subject>p38 Mitogen-Activated Protein Kinases - antagonists & inhibitors</subject><subject>Phosphorylation - drug effects</subject><subject>Phosphoserine - metabolism</subject><subject>Protein Biosynthesis - drug effects</subject><subject>Protein Kinase Inhibitors - pharmacology</subject><subject>Pyridines - pharmacology</subject><subject>SB202190</subject><subject>SB203580</subject><subject>Stress, Physiological - drug effects</subject><subject>Stress-activated protein kinase</subject><subject>Substrate Specificity - drug effects</subject><subject>Suppression, Genetic - drug effects</subject><issn>1976-6696</issn><issn>1976-670X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2009</creationdate><recordtype>article</recordtype><recordid>eNpVkNtKAzEQhoMoWqtvoJIX6Do5bJK9EWzxhFWhKngXstmsjbSbJVsL9elNqcfcTObP_N-EH6EjAlnOFTst52V0bUYBiozTjGWE0y3UI4UUAyHhZfv7Lgqxh_a77g1AECrpLtojBWMCAHpoeh-aQdc662tvsW_w0i9DqlNf-oUPDQ41Ht0SXK7wYupwu4q-8s1qhv3cV-YjzJLG1LchxA4_DjEFlivApqk2HSUFHKCd2sw6d_hV--j58uJpdD0YP1zdjM7HA5vzfJF-Sx2xNZjS5ca6dAQkIeHAqIrLSjFFla0V49SWwkCuKiFVZSU4aZRifXS24bbv5dxV1jWLaGa6jX5u4koH4_X_l8ZP9WtYas4JVVIkAN8AbAxdF1394yWg18nr4d1w4lq9Tl5zqplOySfbyd-9v6avqNPA8WagNkGb1-g7fTtZMwA4kzn7BNYUiL4</recordid><startdate>20090331</startdate><enddate>20090331</enddate><creator>Shanware, Naval P. (The University of Wisconsin-Madison Medical School, WI, Madison, USA)</creator><creator>Williams, Leah M. (The University of Wisconsin-Madison Medical School, WI, Madison, USA)</creator><creator>Bowler, Michael J. (The University of Wisconsin-Madison Medical School, WI, Madison, USA)</creator><creator>Tibbetts, Randal S. (The University of Wisconsin-Madison Medical School, WI, Madison, USA), E-mail: rstibbetts@wisc.edu</creator><scope>FBQ</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>5PM</scope></search><sort><creationdate>20090331</creationdate><title>Non-specific in vivo inhibition of CK1 by the pyridinyl imidazole p38 inhibitors SB 203580 and SB 202190</title><author>Shanware, Naval P. (The University of Wisconsin-Madison Medical School, WI, Madison, USA) ; Williams, Leah M. (The University of Wisconsin-Madison Medical School, WI, Madison, USA) ; Bowler, Michael J. (The University of Wisconsin-Madison Medical School, WI, Madison, USA) ; Tibbetts, Randal S. (The University of Wisconsin-Madison Medical School, WI, Madison, USA), E-mail: rstibbetts@wisc.edu</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c545t-662e1cf0abe5aceeee60e1c5800a8d47d83828cf8342cb6a058d678dc70e7a883</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2009</creationdate><topic>Casein kinase</topic><topic>Casein Kinase I - antagonists & inhibitors</topic><topic>Cell Line</topic><topic>CICLOHEXIMIDA</topic><topic>CK1</topic><topic>CK2</topic><topic>CREB</topic><topic>Cyclic AMP Response Element-Binding Protein - metabolism</topic><topic>CYCLOHEXIMIDE</topic><topic>Humans</topic><topic>Imidazoles - pharmacology</topic><topic>Non-specific</topic><topic>p38</topic><topic>p38 Mitogen-Activated Protein Kinases - antagonists & inhibitors</topic><topic>Phosphorylation - drug effects</topic><topic>Phosphoserine - metabolism</topic><topic>Protein Biosynthesis - drug effects</topic><topic>Protein Kinase Inhibitors - pharmacology</topic><topic>Pyridines - pharmacology</topic><topic>SB202190</topic><topic>SB203580</topic><topic>Stress, Physiological - drug effects</topic><topic>Stress-activated protein kinase</topic><topic>Substrate Specificity - drug effects</topic><topic>Suppression, Genetic - drug effects</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Shanware, Naval P. (The University of Wisconsin-Madison Medical School, WI, Madison, USA)</creatorcontrib><creatorcontrib>Williams, Leah M. (The University of Wisconsin-Madison Medical School, WI, Madison, USA)</creatorcontrib><creatorcontrib>Bowler, Michael J. (The University of Wisconsin-Madison Medical School, WI, Madison, USA)</creatorcontrib><creatorcontrib>Tibbetts, Randal S. (The University of Wisconsin-Madison Medical School, WI, Madison, USA), E-mail: rstibbetts@wisc.edu</creatorcontrib><collection>AGRIS</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>BMB reports</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Shanware, Naval P. (The University of Wisconsin-Madison Medical School, WI, Madison, USA)</au><au>Williams, Leah M. (The University of Wisconsin-Madison Medical School, WI, Madison, USA)</au><au>Bowler, Michael J. (The University of Wisconsin-Madison Medical School, WI, Madison, USA)</au><au>Tibbetts, Randal S. (The University of Wisconsin-Madison Medical School, WI, Madison, USA), E-mail: rstibbetts@wisc.edu</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Non-specific in vivo inhibition of CK1 by the pyridinyl imidazole p38 inhibitors SB 203580 and SB 202190</atitle><jtitle>BMB reports</jtitle><addtitle>BMB Rep</addtitle><date>2009-03-31</date><risdate>2009</risdate><volume>42</volume><issue>3</issue><spage>142</spage><epage>147</epage><pages>142-147</pages><issn>1976-6696</issn><eissn>1976-670X</eissn><abstract>Small-molecule inhibitors of protein kinases have contributed immensely to our understanding of biological signaling pathways and have been exploited therapeutically for the treatment of cancers and other disease states. The pyridinyl imidazole compounds SB 203580 and SB 202190 were identified as ATP competitive antagonists of the p38 stress-activated protein kinases and have been widely used to elucidate p38-dependent cellular processes. Here, we identify S8 203580 and SB 202190 as potent inhibitors of stress-induced CREB phosphorylation on Serine 111 (Ser-111) in intact cells. Unexpectedly, we found that the inhibitory activity of SB 203580 and SB 202190 on CREB phosphorylation was independent of p38, but instead correlated with inhibition of casein kinase 1 (CK1) in vitro. The inhibition of CK1-mediated CREB phosphorylation by concentrations of pyridinyl imidazoles commonly employed to suppress p38, suggests that in some cases conclusions of p38-dependence derived solely from the use of these inhibitors may be invalid.</abstract><cop>Korea (South)</cop><pmid>19336000</pmid><doi>10.5483/bmbrep.2009.42.3.142</doi><tpages>6</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1976-6696 |
ispartof | BMB reports, 2009-03, Vol.42 (3), p.142-147 |
issn | 1976-6696 1976-670X |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4412876 |
source | Free Full-Text Journals in Chemistry |
subjects | Casein kinase Casein Kinase I - antagonists & inhibitors Cell Line CICLOHEXIMIDA CK1 CK2 CREB Cyclic AMP Response Element-Binding Protein - metabolism CYCLOHEXIMIDE Humans Imidazoles - pharmacology Non-specific p38 p38 Mitogen-Activated Protein Kinases - antagonists & inhibitors Phosphorylation - drug effects Phosphoserine - metabolism Protein Biosynthesis - drug effects Protein Kinase Inhibitors - pharmacology Pyridines - pharmacology SB202190 SB203580 Stress, Physiological - drug effects Stress-activated protein kinase Substrate Specificity - drug effects Suppression, Genetic - drug effects |
title | Non-specific in vivo inhibition of CK1 by the pyridinyl imidazole p38 inhibitors SB 203580 and SB 202190 |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-10T17%3A00%3A17IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Non-specific%20in%20vivo%20inhibition%20of%20CK1%20by%20the%20pyridinyl%20imidazole%20p38%20inhibitors%20SB%20203580%20and%20SB%20202190&rft.jtitle=BMB%20reports&rft.au=Shanware,%20Naval%20P.%20(The%20University%20of%20Wisconsin-Madison%20Medical%20School,%20WI,%20Madison,%20USA)&rft.date=2009-03-31&rft.volume=42&rft.issue=3&rft.spage=142&rft.epage=147&rft.pages=142-147&rft.issn=1976-6696&rft.eissn=1976-670X&rft_id=info:doi/10.5483/bmbrep.2009.42.3.142&rft_dat=%3Cpubmed_cross%3E19336000%3C/pubmed_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c545t-662e1cf0abe5aceeee60e1c5800a8d47d83828cf8342cb6a058d678dc70e7a883%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/19336000&rfr_iscdi=true |